微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 1.8% | -28% | -64.36% | 45/140 | 1.2% | 维力医疗 | 5.45% | 行业排名> |
| 2025-12-31 | 5.05% | -33.02% | 10.75% | 54/140 | 2.37% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-09-30 | 4.56% | -37.1% | 61.13% | 61/140 | 4.19% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-06-30 | 2.83% | -42.94% | 13.2% | 59/140 | 2.43% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-03-31 | 2.5% | -22.12% | -66.84% | 33/140 | 1.42% | 惠泰医疗 | 15.03% | 行业排名> |
| 2024-12-31 | 7.54% | -6.68% | 4% | 46/140 | 4.14% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-09-30 | 7.25% | -16.76% | 46.17% | 40/140 | 5.03% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-06-30 | 4.96% | -11.27% | 54.52% | 39/140 | 3.15% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-03-31 | 3.21% | -4.46% | -60.27% | 22/140 | 1.75% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2023-12-31 | 8.08% | -42.74% | -7.23% | 50/140 | 5.44% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-09-30 | 8.71% | -29.42% | 55.81% | 38/140 | 6.06% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-06-30 | 5.59% | -23.95% | 66.37% | 40/140 | 3.96% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-03-31 | 3.36% | 8.74% | -76.19% | 35/140 | 2.33% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2022-12-31 | 14.11% | 6.73% | 14.34% | 43/140 | 13.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-09-30 | 12.34% | -45.78% | 67.89% | 43/140 | 13.94% | 九安医疗 | 146.56% | 行业排名> |
| 2022-06-30 | 7.35% | 3.52% | 137.86% | 50/140 | 9.74% | 九安医疗 | 140.94% | 行业排名> |
| 2022-03-31 | 3.09% | -78.04% | -76.63% | 54/140 | 6.8% | 九安医疗 | 142.25% | 行业排名> |
| 2021-12-31 | 13.22% | 9.62% | -41.92% | 65/140 | 18.45% | 九安医疗 | 142.71% | 行业排名> |
| 2021-09-30 | 22.76% | 115.12% | 220.56% | 19/140 | 16.59% | 热景生物 | 121.78% | 行业排名> |
| 2021-06-30 | 7.1% | 52.03% | -49.54% | 56/140 | 11.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-03-31 | 14.07% | 406.12% | 16.67% | 10/140 | 6.49% | 热景生物 | 99.09% | 行业排名> |
| 2020-12-31 | 12.06% | 0.5% | 13.99% | 79/140 | 26.27% | 热景生物 | 57.63% | 行业排名> |
| 2020-09-30 | 10.58% | 5.17% | 126.55% | 51/140 | 19.98% | 中红医疗 | 168% | 行业排名> |
| 2020-06-30 | 4.67% | 2% | 67.99% | 73/140 | 15.17% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-03-31 | 2.78% | 36.27% | -76.83% | 30/140 | 3.31% | 博拓生物 | 108.13% | 行业排名> |
| 2019-12-31 | 12% | 107.97% | 19.28% | 68/140 | 14.66% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-09-30 | 10.06% | 2% | 393.14% | 29/140 | 10.54% | 健尔康 | 84.09% | 行业排名> |
| 2019-03-31 | 2.04% | 2% | -64.64% | 32/140 | 2.73% | 祥生医疗 | 28.56% | 行业排名> |
| 2018-12-31 | 5.77% | 12.04% | 12.04% | 87/140 | 14.23% | 心脉医疗 | 31.04% | 行业排名> |
| 2017-12-31 | 5.15% | -69.76% | -69.76% | 82/140 | 14.51% | 新华医疗 | 13.55% | 行业排名> |
| 2016-12-31 | 17.03% | 2% | 2% | 30/140 | 16.44% | 安旭生物 | 48.71% | 行业排名> |